Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 10
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04855760 | Safety of REL-1017 for Major Depressive Disorder | ||
| NCT07313891 | A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT | ||
| NCT05081167 | A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD) | ||
| NCT03637361 | Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone) | ||
| NCT07342517 | A Phase 3 Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy | ||
| NCT03638869 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone) | ||
| NCT04688164 | A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) | ||
| NCT06663137 | Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC | ||
| NCT06009003 | Individual Patient Esmethadone (REL-1017) Expanded Access Program | ||
| NCT03051256 | Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD |
